Bioethics of intervention and the case of drugs Bevacizumab and Ranibizumab for retinal diseases

From the year 2000, on a class of biological drugs, the anti-VEGF proved to be quite effective in the treatment of retinal diseases, which have in its pathophysiological mechanism an important vascular proliferation component that can lead to blindness. Two of these drugs, bevacizumab and ranibizuma...

Full description

Bibliographic Details
Main Author: Flávio R. L. Paranhos
Format: Article
Language:English
Published: Universidad Pontificia Comillas 2016-10-01
Series:Revista Iberoamericana de Bioética
Subjects:
Online Access:http://revistas.upcomillas.es/index.php/bioetica-revista-iberoamericana/article/view/7346